Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 165 | 332 | 202 | 212 | 122 |
| Cost of Goods | 102 | 230 | 67 | 70 | 54 |
| Gross Profit | 63 | 102 | 135 | 142 | 68 |
| Operating Expenses | 4,168 | 2,610 | 2,690 | 3,014 | 6,623 |
| Operating Income | -4,003 | -2,278 | -2,488 | -2,802 | -6,501 |
| Other Income | -27 | 29 | 46 | 17 | -2 |
| Pre-tax Income | -4,030 | -2,249 | -2,442 | -2,785 | -6,503 |
| Net Income Continuous | -4,030 | -2,249 | -2,442 | -2,785 | -6,503 |
| Net Income | $-4,030 | $-2,249 | $-2,442 | $-2,785 | $-6,503 |
| EPS Basic Total Ops | -0.08 | -0.04 | -0.05 | -0.05 | -0.12 |
| EPS Basic Continuous Ops | -0.08 | -0.04 | -0.05 | -0.05 | -0.13 |
| EPS Diluted Total Ops | -0.08 | -0.04 | -0.05 | -0.05 | -0.12 |
| EPS Diluted Continuous Ops | -0.08 | -0.04 | -0.05 | -0.05 | -0.13 |
| EBITDA(a) | $-3,850 | $-2,106 | $-2,318 | $-2,640 | $-6,336 |